Tradeoffs When Selling a Medical Practice to Private Equity
- 6 hours ago
- 5 min read
We get questions in our online physician community from private practice owners approached by private equity groups interested in buying their practice. Selling your medical practice to private equity is often framed as a path to liquidity and financial freedom. But it is not just a transaction, it is a fundamental shift in control, risk, and incentives. Upfront cash may be attractive, but the long-term consequences are rarely visible at the signing table. For physicians evaluating a sale to private equity, three core considerations often influence how the practice operates and how professional responsibilities shift after closing: change in authority, standardization of practices, and shifts in risk. We discuss each of these below.
The information for this article is original material contributed by Trevor Anderson, a healthcare attorney who specializes in helping physicians navigate the business of healthcare, including mergers and acquisitions. Trevor is a paid advertiser in our attorney database for physicians and offers PSG members a special perk.
Disclosure/Disclaimer: Our content is for generalized educational purposes. Please do your own due diligence before making decisions based on this page. Nothing on this page constitutes formal or personalized legal or financial advice. Laws and taxes vary based on location and while this information is accurate to the best of our knowledge, it may not be up to date or apply in your location or personal situation. We are not formal financial, legal, or tax professionals, and you should consult these as appropriate. To learn more, visit our disclaimers and disclosures.
Consider what authority you are permanently transferring when selling your medical practice
Many physicians assume that selling to private equity will leave clinical and operational control largely intact. In practice, that is rarely the case.
Once a majority stake is sold, shifts in governance may be subtle, or jarring, depending on the aggressiveness of the private equity group. Following the sale, the board will usually fall under the control of the private equity group, and major decisions require an affirmative vote from the board. As a result, physicians will have limited ability to approve changes that affect staffing, finances, or the direction of the practice. Even areas that may fall under the physician’s purview, such as staffing decisions or departmental protocols, may be subject to centralized approval or standardized metrics.
One of the most tangible ways physicians feel the shift in control is through changes to compensation and operational authority. Compensation structures are often redesigned to meet margin and performance targets set by the private equity group. Physicians may find, for instance, that the practice shifts from a traditional profit-sharing model to one tied directly to productivity metrics, patient volume, or collections efficiency. Physician schedules may be standardized to maximize throughput, ancillary services may be bundled or centralized, and certain high-cost procedures may require approval before being offered.
Daily operational choices may remain in the physician’s hands, but larger strategic or financial decisions are increasingly filtered through the group’s priorities. For example, a physician may want to invest in new imaging equipment to improve patient care, but the private equity group may block the purchase if the expected return does not meet internal targets. Similarly, expanding a specialty clinic or hiring a high-cost specialist may be deferred or rejected, even if clinically justified, because it does not align with the platform’s broader growth strategy.
Misjudging where authority truly resides can have real consequences, affecting professional satisfaction, staff morale, and the long-term trajectory of the practice.
Consider how standardization affects the way physicians practice before selling to a private equity group
Selling a practice to private equity often introduces a new layer of standardization that reshapes how physicians work. Metrics and protocols designed to optimize efficiency and scalability can dictate everything from patient scheduling to clinical workflows. For example, a physician who previously set their own appointment lengths may now be required to follow standardized slot times to maximize output. Even referral patterns that once prioritized continuity of care may be adjusted to align with network-wide revenue targets.
These changes can be reinforced by incentive structures that reward adherence to these standards rather than discretionary judgment. Physicians may receive bonuses tied to patient volume, procedural efficiency, or adherence to protocol checklists, subtly shifting priorities away from individualized care.
Staff roles can also be affected; for instance, medical assistants or front-desk staff may be cross-trained or reassigned to meet productivity targets, which changes team dynamics and the usual workflow physicians are accustomed to.
The cumulative effect of standardization and performance-driven incentives is often gradual but tangible. Physicians may feel constrained in their ability to make patient-centered decisions, and long-standing workflows that supported staff cohesion and professional satisfaction may be altered.
While authority over minor day-to-day choices remains, these standardized systems fundamentally change how physicians practice, how teams operate, and how the culture of the clinic feels. Over time, these shifts can influence engagement, satisfaction, and retention of both physicians and staff.
How risk shifts after selling your medical practice to a private equity group
Trevor Anderson, a corporate healthcare attorney and Managing Partner of The Anderson Firm, P.C., informs that selling to private equity does not remove risk, it reallocates it. Anderson cautions, “Many physicians assume that cashing out shields them from operational or market risks, but that’s rarely true. After a sale, they often face employment agreements with non-competition, non-solicitation, or other restrictive clauses that limit their flexibility. Strict termination provisions can also make it difficult to leave or make changes without facing consequences.”
Related PSG resources:
Even if a practice is generating steady revenue, the private equity group’s broader financial obligations can create pressures that affect local operations. For instance:
A private equity-backed platform might require a practice to consolidate lab or imaging services with another location to reduce costs, even if it makes scheduling less convenient for patients.
A practice may also be asked to renegotiate vendor contracts or switch suppliers to improve margins, regardless of existing relationships or quality considerations.
Expansion into a new clinic site or the purchase of additional equipment could be postponed if the private equity group prioritizes debt repayment or platform-level cash flow.
In all these cases, physicians have limited ability to veto decisions, and the risk of operational or financial consequences is largely outside their control.
Conclusion
Selling a practice to private equity is not simply monetizing an asset. It is exchanging autonomy for liquidity, ownership for oversight, and long-term control for the promise of growth-driven payouts. For some physicians, the trade-off is worthwhile. For others, the realities of diminished authority, operational realignment, and redistributed risk become clear only after the deal closes.
The critical questions are not always about valuation or headline multiples. They are about who truly controls decisions after closing, how incentives and daily operations will change, and where risk now resides. Examining these questions candidly before signing ensures that the physician is not selling more than cash; they are selling a way of working, a set of professional freedoms, and a career trajectory. Once the deal closes, renegotiating these trade-offs is extremely difficult.
Additional resources for private practice physicians
If you need help evaluating and negotiating a potential sale of your medical practice, reach out to one of the healthcare attorneys on our database.
Sign up for our PSG weekly newsletter for alerts of upcoming free private practice educational webinars, alerts of new member perks & resources, additional educational content, and more.
Explore related PSG content: